Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Tofacitinib helped regrow hair in most patients with severe hair loss.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Three compounds from Dadap leaves may help treat hair loss.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

JAK inhibitors may help improve symptoms in adults with APECED.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

JAK inhibitors may reduce depression in people with alopecia areata.

JAK inhibitors show promise for treating various skin diseases.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

JAK inhibitors offer new hope for treating severe alopecia areata.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.